Prevalence of hepatitis B virus infection in a highly endemic area of southern China after catch-up immunization

Journal of Medical Virology

Volumn 84, Issue 6, 2012, Pages 878-884

  Fang, Zhong Liao ^a   Harrison, Tim J ^b   Yang, Jin Ye ^a   Chen, Qin Yan ^a   Wang, Xue Yan ^a   Mo, Jian Jun ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Epidemiology; Guangxi; HBsAg; Hepatitis B virus; Immunization

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CHINA; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION RISK; MALE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEROEPIDEMIOLOGY; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; ENDEMIC DISEASES; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84859772887     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23278     Document Type: Article

References (34)

1. André F. 2000. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18: S20- S22.
2. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM. 2003. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Saudi Med J 24: 991- 995.
3. Centers for Disease Control and Prevention (CDC). 2006. Hepatitis B vaccination coverage among adults-United States, 2004. Morb Mortal Wkly Rep 55: 509- 511.
4. Chen DS. 1993. From hepatitis to hepatoma: Lessons from type B viral hepatitis. Science 262: 369- 370.
5. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS. 1996. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 276: 906- 908.
6. Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Wiersma S, Nymadawa P, Nakamura Y. 2007. Impact of the universal hepatitis B immunization program in Mongolia: Achievements and challenges. J Epidemiol 17: 69- 75.
7. Ding ZR. 1982. Distribution of viral hepatitis B infection in Guangsi Province. Zhonghua Liu Xing Bing Xue Za Zhi 3: 84- 87.
8. Du F, Liu QL, Fu QP, Sun L, Ao R, Guan XJ, Liu Y, Wang J, He H, Tong WB, Qin ZY, Fan WJ, Li J, He JL, Fang G. 2009. A seroepidemiologic analysis of hepatitis B in Sichuan province. Zhonghua Liu Xing Bing Xue Za Zhi 30: 139- 143.
9. Hutton DW, So SK, Brandeau ML. 2010. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology 51: 405- 414.
10. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. 2009a. Epidemiological serosurvey of hepatitis B in China-Declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550- 6557.
11. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. 2009b. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 200: 39- 47.
12. Luo Z, Xie Y, Deng M, Zhou X, Ruan B. 2011. Prevalence of hepatitis B in the southeast of China: A population-based study with a large sample size. Eur J Gastroenterol Hepatol 23: 695- 700.
13. Margolis HS. 1998. Fact sheets for candidate diseases for elimination or eradication. Hepatitis B virus infection. Bull World Health Organ 76: 152- 153.
14. Margolis HS, Alter JH, Hadler SC. 1991. Hepatitis B: Evolving epidemiology and implications for control. Semin Liver Dis 11: 84- 92.
15. Mathew JL, El Dib R, Mathew PJ, Boxall EH, Brok J. 2008. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status. Cochrane Database Syst Rev 3: CD006481.
16. Maynard JE. 1990. Hepatitis B: Global importance and need for control. Vaccine 8: S18- S20.
17. Ministry of Health. 2005. National EPI review in 2004. Beijing: Chinese People's Health Express, p 24.
18. Ministry of Health. 2006. 2006-2010 National guidelines for hepatitis B prevention and treatment. China: Ministry of Health, p 2.
19. Namgyal P. 2003. Impact of hepatitis B immunization, Europe and worldwide. J Hepatol 39: S77- S82.
20. Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M. 2005. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 194: 163- 168.
21. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, Chen DS. 2007. Two decades of universal hepatitis B vaccination in Taiwan: Impact and implication for future strategies. Gastroenterology 132: 1287- 1293.
22. Pereira LM, Martelli CM, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima ML, Cardoso MR, Turchi MD, Costa MA, de Alencar LC, Moreira RC, Figueiredo GM, Ximenes RA. 2009. Hepatitis Study Group. Population-based Multicentric Survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 81: 240- 247.
23. Romano' L, Paladini S, Van Damme P, Zanetti AR. 2011. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis 43: S2- S7.
24. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. 2006. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiol Rev 28: 112- 125.
25. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, Whittle HC. 1999. Hepatitis B vaccination in infancy in The Gambia: Protection against carriage at 9 years of age. Vaccine 17: 2946- 2950.
26. Wang SS. 1995. Evaluation of the Hepatitis B Model Immunization Program in long an County, China. Guangxi J Prev Med 1: 1- 4.
27. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B. 2010. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 202: 192- 201.
28. World Health Organization. 1992. WHO expanded programme on immunisation. Global Advisory Group. Weekly Epidemiol Rec 3: 11- 16.
29. World Health Organization. Hepatitis B. Accessed 11/10/2008.
30. Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M. 2011. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: Results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine 29: 2302- 2307.
31. Yao JL. 1996. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut 38: S37- S38.
32. Zanetti AR, Van Damme P, Shouval D. 2008. The global impact of vaccination against hepatitis B: A historical overview. Vaccine 26: 6266- 6273.
33. Zhang H, Li Q, Sun J, Wang C, Gu Q, Feng X, Du B, Wang W, Shi X, Zhang S, Li W, Jiang Y, Feng J, He S, Niu J. 2011. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. Int J Med Sci 8: 321- 331.
34. Zhou LH, Li XQ, Ye DQ, Zheng YJ, Ge FY, Cai B, Huang F. 2009. A cross-sectional survey on hepatitis B among general population in areas along Yangzi River in Anhui province. Zhonghua Liu Xing Bing Xue Za Zhi 30: 144- 146.